Evidence map›Paper›PMID 23233369›Full record

ArticleArthritis and rheumatism2013

Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.

Jianru Wang, Ye Tian, Kate L E Phillips, Neil Chiverton, Gail Haddock, Rowena A Bunning, Alison K Cross, Irving M Shapiro, Christine L Le Maitre, Makarand V Risbud

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 183 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. IL-15 and IL-21 synergy improves anti-tumor efficacy of iPSC-derived cytotoxic T cells in solid tumors.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  5. Article
  6. Bone and Infections: An Osteoimmunological Interplay.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Jianru WangThomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Ye Tian
Kate L E Phillips
Neil Chiverton
Gail Haddock
Rowena A Bunning
Alison K Cross
Irving M Shapiro
Christine L Le Maitre
Makarand V Risbud
Sheffield Hallam University · GBThomas Jefferson University · USSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

Role of HIF-1 in Intervertebral Disc FunctionR01AR055655 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V · 2008 to 2023
$6.1M
Regeneration of Nucleus Pulposus by Tissue EngineeringR01AR050087 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V, SHAPIRO, IRVING M · 2005 to 2013
$3.0M
Role of HIF-1 in intervertebral disc functionR56AR055655 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V · 2024 to 2024
$312k
NIAMS NIH HHS AR-050087NIAMS NIH HHS AR-055655NIAMS NIH HHS R01 AR050087NIAMS NIH HHS R01 AR055655NIAMS NIH HHS R56 AR055655
6 · The paper itself

Abstract

objectiveTo investigate tumor necrosis factor α (TNFα) and interleukin-1β (IL-1β) regulation of CCL3 expression in nucleus pulposus (NP) cells and in macrophage migration.

methodsQuantitative reverse transcription-polymerase chain reaction and immunohistochemistry were used to measure CCL3 expression in NP cells. Transfections were used to determine the role of NF-κB, CCAAT/enhancer binding protein (C/EBPβ), and MAPK on cytokine-mediated CCL3 promoter activity. The effect of NP-conditioned medium on macrophage migration was measured using a Transwell system.

resultsAn increase in CCL3 expression and promoter activity was observed in NP cells after TNFα or IL-1β treatment. Treatment of cells with NF-κB and MAPK inhibitors abolished the effect of the cytokines on CCL3 expression. The inductive effect of p65 and C/EBPβ on the CCL3 promoter was confirmed through gain-of-function and loss-of-function studies. Notably, cotransfection with p50 completely blocked cytokine- and p65-dependent induction. In contrast, c-Rel and RelB had little effect on promoter activity. Lentiviral transduction with short hairpin RNA for p65 (shp65) and shIKKβ significantly decreased the TNFα-dependent increase in CCL3 expression. Analysis of degenerated human NP tissue samples showed that CCL3, but not CCL4, expression correlated positively with the grade of tissue degeneration. Importantly, treatment of macrophages with conditioned medium of NP cells treated with TNFα or IL-1β promoted their migration. Pretreatment of macrophages with an antagonist of CCR1, the primary receptor for CCL3 and CCL4, blocked cytokine-mediated migration.

conclusionOur findings indicate that TNFα and IL-1β modulate the expression of CCL3 in NP cells by controlling the activation of MAPK, NF-κB, and C/EBPβ signaling. The CCL3-CCR1 axis may play an important role in promoting macrophage infiltration in degenerated, herniated discs.

Indexed as

AnimalsCCAAT-Enhancer-Binding Protein-betaCell MovementChemokine CCL3Chemokine CCL4HumansInterleukin-1betaIntervertebral DiscIntervertebral Disc DegenerationMacrophagesMAP Kinase Signaling SystemNF-kappa BPromoter Regions, GeneticRatsRats, WistarReceptors, CCR1CCAAT-Enhancer-Binding Protein-betaCCL3 protein, humanCCL4 protein, humanCCR1 protein, humanCcr1 protein, ratChemokine CCL3Chemokine CCL4Interleukin-1betaNF-kappa BReceptors, CCR1Tumor Necrosis Factor-alpha

Identifiers

PMID23233369
PMCPMC3582738
OpenAlexW2069714642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.